Poly-Vent IR Drug Interactions
Currently displaying a list of 220 drugs known to interact with Poly-Vent IR (guaifenesin / pseudoephedrine).
- 21 major drug interactions
- 193 moderate drug interactions
- 6 minor drug interactions
Medications known to interact with Poly-Vent IR
Note: Showing generic names only.
- acarbose
- acebutolol
- acetohexamide
- albiglutide
- albuterol
- alfuzosin
- alogliptin
- amifampridine
- aminophylline
- amitriptyline
- ammonium chloride
- amoxapine
- amphetamine
- apraclonidine ophthalmic
- arformoterol
- armodafinil
- ascorbic acid
- atenolol
- atomoxetine
- caffeine
- canagliflozin
- carvedilol
- chlorpromazine
- chlorpropamide
- clomipramine
- cocaine nasal
- cocaine topical
- dapagliflozin
- deserpidine
- desflurane
- desipramine
- desvenlafaxine
- dexmethylphenidate
- dextroamphetamine
- diethylpropion
- digitoxin
- digoxin
- dihydroergotamine
- dobutamine
- dopamine
- doxapram
- doxazosin
- doxepin
- droxidopa
- dulaglutide
- duloxetine
- empagliflozin
- enflurane
- ephedrine
- epinephrine
- epoprostenol
- ergonovine
- ergotamine
- ertugliflozin
- esmolol
- evening primrose
- exenatide
- idelalisib
- iloprost
- imipramine
- indacaterol
- insulin
- insulin aspart
- insulin aspart protamine
- insulin degludec
- insulin detemir
- insulin glargine
- insulin glulisine
- insulin inhalation, rapid acting
- insulin isophane
- insulin lispro
- insulin lispro protamine
- insulin regular
- insulin zinc
- insulin zinc extended
- iobenguane I 123
- iobenguane I 131
- iohexol
- iomeprol
- iopamidol
- isocarboxazid
- isoetharine
- isoflurane
- isoproterenol
- labetalol
- landiolol
- levalbuterol
- levodopa
- levomilnacipran
- levothyroxine
- linagliptin
- lindane topical
- linezolid
- liothyronine
- liraglutide
- lisdexamfetamine
- lixisenatide
- ma huang
- mazindol
- mecamylamine
- mephentermine
- mesoridazine
- metaproterenol
- metaraminol
- metformin
- methamphetamine
- methdilazine
- methionine
- methotrimeprazine
- methoxamine
- methoxyflurane
- methyldopa
- methylene blue
- methylergonovine
- methylphenidate
- methysergide maleate
- metoprolol
- metrizamide
- midodrine
- miglitol
- milnacipran
- modafinil
- perphenazine
- phendimetrazine
- phenelzine
- phenoxybenzamine
- phentermine
- phentolamine
- phenylephrine
- phenylpropanolamine
- pindolol
- pioglitazone
- pirbuterol
- polyethylene glycol 3350 with electrolytes
- potassium acid phosphate
- potassium citrate
- pramlintide
- prazosin
- procarbazine
- prochlorperazine
- promazine
- promethazine
- propiomazine
- propranolol
- protriptyline
- safinamide
- salmeterol
- saxagliptin
- selegiline
- selexipag
- semaglutide
- sevoflurane
- sibutramine
- silodosin
- sitagliptin
- sodium acetate
- sodium bicarbonate
- sodium citrate
- sodium lactate
- solriamfetol
- sotagliflozin
- sotalol
- tamsulosin
- tapentadol
- terazosin
- terbutaline
- theophylline
- thiethylperazine
- thioridazine
- thyroid desiccated
- timolol
- tirzepatide
- tolazamide
- tolazoline
- tolbutamide
- tramadol
- tranylcypromine
- treprostinil
- trifluoperazine
- triflupromazine
- trimeprazine
- trimipramine
- troglitazone
- tromethamine
Poly-Vent IR alcohol/food interactions
There is 1 alcohol/food interaction with Poly-Vent IR (guaifenesin / pseudoephedrine).
Poly-Vent IR disease interactions
There are 6 disease interactions with Poly-Vent IR (guaifenesin / pseudoephedrine) which include:
More about Poly-Vent IR (guaifenesin / pseudoephedrine)
- Poly-Vent IR consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- Drug class: upper respiratory combinations
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.